Norris Medicines Financials

BSE: 524414

₹13.65

₹-0.64 (-4.48%)

As on 04-Sep-2026IST

Market cap

₹14 Cr

Revenue (TTM)

₹8 Cr

P/E Ratio

--

P/B Ratio

-0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	7.60	5.82	5.64	8.36	9.44	12.25
Total Income	7.62	5.88	5.66	8.37	9.46	12.30
Total Expenditure	7.12	6.08	5.82	7.44	9.51	14.00
EBITDA	0.48	-0.26	-0.18	0.92	-0.07	-1.74
Depreciation	0.48	0.54	0.57	0.63	0.66	0.67
EBIT	0.00	-0.80	-0.76	0.29	-0.73	-2.41
Interest	0.39	0.44	0.37	1.50	1.48	1.63
Other Income	0.02	0.06	0.03	0.01	0.03	0.05
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.37	-1.18	-1.10	-1.19	-2.18	-3.99
Provision for Tax	--	0.06	0.09	0.56	1.08	0.97
Profit after Tax	-0.37	-1.24	-1.19	-1.75	-3.26	-4.96

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	-15.15	-14.87	-13.63	-12.44	-10.69	-7.43
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	18.51	17.62	17.63	17.37	16.49	12.84
Current Liabilities	9.53	10.15	9.23	7.70	6.78	11.69
Total Liabilities	12.89	13.81	14.19	13.69	14.19	19.79

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	4.90	6.57	7.08	7.71	8.31	8.87
Current Assets	5.81	6.34	6.14	4.92	4.27	8.23
Total Assets	12.89	13.81	14.19	13.69	14.19	19.79
Total Debt*	--	21.58	21.52	21.40	21.08	18.39
Net Current Assets	-3.71	-3.81	-3.08	-2.78	-2.51	-3.46
Contingent Liabilities	--	1.33	1.33	1.33	1.33	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	0.51	0.17	1.20	-1.01	1.11
Cash Flow from Investing Activities	--	0.00	0.05	-0.02	-0.09	-0.06
Cash from Financing Activities	--	-0.50	-0.20	-1.18	1.10	-1.09
Net Cash Inflow / Outflow	--	0.00	0.02	0.00	0.00	-0.04

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	-0.37	-1.25	-1.20	-1.76	-3.29	-5.00
Cash EPS (₹)	-0.37	-0.71	-0.62	-1.13	-2.63	-4.33
Adjusted Book Value (₹)	-15.47	-14.98	-13.73	-12.54	-10.77	-7.49
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.51	0.17	1.21	-1.02	1.12
Free Cash Flow per Share (₹)	--	0.01	-0.30	-0.88	-3.64	-1.49

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	-10.11	-8.64	3.17	-6.59	-17.87
ROE (%)	--	--	--	--	--	--
ROA (%)	-2.75	-9.47	-9.18	-13.88	-21.99	-29.19
EBIT Margin (%)	-0.01	-13.74	-13.42	3.50	-7.72	-19.68
Net Margin (%)	-4.82	-21.04	-20.95	-20.90	-34.48	-40.33
Cash Profit Margin (%)	0.00	-12.04	-10.92	-13.40	-27.62	-35.06

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	16.00	3.27	-32.57	-11.45	-22.96	56.19
EBIT Growth (%)	99.86	-5.74	-358.58	140.14	69.78	16.39
Net Profit Growth (%)	69.00	-4.28	32.17	46.39	34.23	-74.65
EPS Growth (%)	69.00	-4.27	32.17	46.39	34.23	-74.65
Book Value Growth (%)	--	-9.08	-9.54	-16.36	-43.92	-201.02

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-37.20	--	--	--	--	--
Price / Book Value	-0.88	-1.12	-0.99	-0.83	--	-0.87
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	69.63	-189.57	-223.49	33.90	-672.01	-14.67
Close Price (₹)	14.84	16.78	13.60	10.45	--	6.50
High Price (₹)	19.25	27.74	27.51	33.25	--	6.50
Low Price (₹)	12.00	10.70	10.00	8.09	--	2.45
Market Cap (₹ Cr)	13.65	16.66	13.50	10.37	--	6.45

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	-1.22	-1.45	-1.58	-1.72	-1.97	-2.47
Short term debt to equity ratio	--	-0.21	-0.22	-0.24	-0.28	-0.39
Current Ratio	0.61	0.62	0.67	0.64	0.63	0.70
Quick Ratio	0.19	0.22	0.20	0.22	0.27	0.27
Interest Coverage	0.05	-1.68	-1.97	0.20	-0.47	-1.44

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	15.45	24.21	18.82	13.17	11.57	14.60
Asset Turnover	0.57	0.45	0.44	0.66	0.64	0.72
Receivable days	--	77.44	69.98	47.88	55.70	67.77
Inventory Days	--	265.33	243.91	122.70	145.47	135.68
Payable days	--	229.77	216.62	146.80	213.75	169.83
Cash Conversion Cycle	--	113.00	97.28	23.78	-12.58	33.62

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.